Woo Chul Noh

7PUBLICATIONS
31CO-AUTHORS
Cancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 10, 2024
CTLA4 expression profiles and their association with clinical outcomes of breast cancer: a systemic review.

TongYi Jin, Kyoung Sik Park, Sang Eun Nam

|Jul 13, 2023
Can chemotherapy be omitted for patients with N0 or N1 endocrine-sensitive breast cancer treated with gonadotropin-releasing hormone agonist and tamoxifen?

Juhyeon Lee, Chan Sub Park, Jeong Hun Oh

|Jul 13, 2023
Survival analysis of breast cancer patients after diagnosis of second primary malignancies, focusing on the second primary hematologic malignancy.

Hyung Jin Kim, Juhyeon Lee, In-Chul Park

|Oct 31, 2022
The Significance of p-AKT1 as a Prognostic Marker and Therapeutic Target in Patients With Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor-2-Positive Early Breast Cancer.

Ji Yea Kim, Chan Sub Park, Se-Kyeong Jang

|Oct 28, 2022
Vitamin D receptor (VDR) mRNA overexpression is associated with poor prognosis in breast carcinoma.

Sang Eun Nam, TongYi Jin, Kyoung Sik Park

|Feb 08, 2022
The Prediction of HER2-Targeted Treatment Response Using 64Cu-Tetra-Azacyclododecanetetra-Acetic Acid (DOTA)-Trastuzumab PET/CT in Metastatic Breast Cancer: A Case Report.

Inki Lee, Ilhan Lim, Byung Hyun Byun

Pageof 2

Frequent Collaborators

5 joint publications

Min-Ki Seong

5 joint publications

Hyun-Ah Kim

4 joint publications

Chan Sub Park

4 joint publications

In-Chul Park